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SUMMARY
Correlative evidence suggests that polyploidization of heart muscle, which occurs naturally in 
post-natal mammals, creates a barrier to heart regeneration. Here, we move beyond a correlation 
by demonstrating that experimental polyploidization of zebrafish cardiomyocytes is sufficient to 
suppress their proliferative potential during regeneration. Initially, we determined that zebrafish 
myocardium becomes susceptible to polyploidization upon transient cytokinesis inhibition 
mediated by dominant negative Ect2. Using a transgenic strategy, we generated adult animals 
containing mosaic hearts composed of differentially labeled diploid and polyploid-enriched 
cardiomyocyte populations. Diploid cardiomyocytes outcompeted their polyploid neighbors in 
producing regenerated heart muscle. Moreover, hearts composed of equivalent proportions of 
diploid and polyploid cardiomyocytes failed to regenerate altogether, demonstrating that a critical 
percentage of diploid cardiomyocytes is required to achieve heart regeneration. Our data identify 
cardiomyocyte polyploidization as a barrier to heart regeneration and suggest that mobilizing rare 
diploid cardiomyocytes in the human heart will improve its regenerative capacity.
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It remains unclear why certain non-mammalian species efficiently regenerate their hearts, while 
mammals fail in this endeavor. Gonzalez-Rosa et al. demonstrate that simply increasing the DNA 
content of the highly regenerative zebrafish myocardium, to more closely resemble that in 
mammals, is sufficient to dampen cardiomyocyte proliferative capacity and organ regeneration.
INTRODUCTION
Cells containing two sets of homologous chromosomes are diploid, while those with greater 
than two complete sets, either enclosed within a single nucleus or separated into multiple 
nuclei, are termed polyploid (Davoli and de Lange, 2011). Polyploid cells arise naturally 
during the maturation of certain lineages when diploid cells fuse or complete DNA 
replication without mitosis and/or cytokinesis (Orr-Weaver, 2015). Although 
polyploidization correlates with terminal differentiation in some lineages, cell cycle exit is 
not a universal feature of polyploid cells. For instance, polyploid hepatocytes contribute 
robustly to regenerated liver segments through proliferation with or without ploidy reversal 
(Duncan et al., 2010). Therefore, the consequences of polyploidization are context specific.
Adult mammalian hearts lack any appreciable capacity to regenerate. By contrast, injured 
hearts of neonatal mice (Porrello et al., 2011) and some non-mammalian vertebrates, 
including salamanders (Becker et al., 1974; Nakamura et al., 2016; Oberpriller and 
Oberpriller, 1974) and zebrafish (González-Rosa and Mercader, 2012; Poss et al., 2002), 
mount an impressive regenerative response driven by myocardial proliferation (Foglia and 
Poss, 2016). Despite their clinical importance, the variables that promote or restrict 
myocardial regeneration remain obscure. One often-noted difference between non-
regenerative and highly regenerative hearts is the DNA content of their cardiomyocytes 
(Bersell et al., 2009; Kikuchi, 2014; Vivien et al., 2016). Specifically, non-regenerative 
hearts contain a majority of polyploid cardiomyocytes (Brodsky et al., 1994) that form early 
in life when their diploid predecessors complete one round of DNA replication without 
mitosis and/or cytokinesis (Alkass et al., 2015; Brodsky et al., 1980; Li et al., 1996; Soonpaa 
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et al., 1996). By contrast, highly regenerative hearts contain a majority of cardiomyocytes 
that are diploid (Oberpriller et al., 1988), or assumed to be diploid based on nucleation 
studies (Wills et al., 2008). Although these observations reveal an inverse correlation 
between ploidy and regeneration in the myocardium, a causal relationship has yet to be 
explored.
In rodents, the transition from diploid (1 × 2c) to polyploid myocardium occurs within the 
first post-natal week and results in myocardium composed of >90% polyploid 
cardiomyocytes that are largely binucleated (2 × 2c) (Li et al., 1996; Soonpaa et al., 1996). 
In humans, myocardial polyploidization occurs within the first two decades, which causes a 
similarly high percentage of cardiomyocytes to become polyploid (Mollova et al., 2013; 
Sandritter and Adler, 1976). However, the adult human heart contains 30% binucleated 
(2x2c) and ~60% mononucleated cardiomyocytes with DNA contents ranging from 4c to 
16c (1x4c, 1x8c, 1x16c). Therefore, polyploid myocardium is a common feature of the non-
regenerative hearts of adult mammals despite species-specific differences in DNA content 
and nuclear number.
In neonatal mice, the timing of myocardial polyploidization coincides with the 
disappearance of cardiac regenerative potential (Porrello et al., 2011), which has led to 
speculation of causality (Vivien et al., 2016). However, the post-natal maturation of the heart 
is accompanied by numerous transitions within cardiomyocytes, resident non-cardiomyocyte 
populations, extra-cardiac cells, and the extra-cellular matrix (Vivien et al., 2016). Despite 
the notion that one or more of these transitions are responsible for suppressing regenerative 
capacity, the causative factors remain largely unidentified.
In an effort to move beyond a correlation, we set out to design an experimental strategy for 
testing the hypothesis that myocardial polyploidization in zebrafish is sufficient to dampen 
heart regeneration. Important features of this system would include: 1) a mechanism for 
creating polyploid cardiomyocytes through inducible cytokinesis inhibition during 
hyperplastic growth of the heart, 2) a counter mechanism for re-enabling cytokinesis during 
adulthood both prior to cardiac injury and during regeneration, and 3) indelible reporter 
labeling of induced polyploid cardiomyocyte populations to compare their regenerative 
capabilities side by side with unlabeled diploid cardiomyocytes in vivo.
Our studies indicate that induced myocardial polyploidization is sufficient to dampen 
cardiomyocyte proliferation in a highly regenerative setting. Moreover, they uncover a 
requirement for a critical percentage (>50%) of diploid cardiomyocytes to achieve heart 
regeneration. Ultimately, these conclusions provide rationale for identifying therapeutic 
approaches to amplify the rare population of diploid cardiomyocytes in the human heart as a 
means to induce natural heart regeneration in disease states.
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RESULTS
Zebrafish cardiomyocytes are mononucleated, diploid, and upregulate Ect2 during heart 
regeneration
Zebrafish cardiomyocytes were assumed to be diploid based on their predominantly 
mononuclear nature (Wills et al., 2008). However, because mononuclear cells can be either 
diploid or polyploid, we set out to make direct measurements of cardiomyocyte ploidy in 
adult animals. To that end, we developed an imaging and analysis platform to survey 
cardiomyocyte nucleation and DNA content in single-cell dissociations of adult ventricles. 
Cardiomyocytes containing a single 2c nucleus (1 × 2c) were categorized as diploid (Figure 
1A), while those containing two ≥2c nuclei (2 × ≥2c) or a single ≥4c nucleus (1 × ≥4c) were 
classified as polyploid. To unequivocally identify cardiomyocytes and distinguish 
multinucleated cells from mononucleated aggregates, we analyzed dissociations from 
Tg(cmlc2:nucGFP), Tg(cmlc2:CAAXmKate) zebrafish in which cardiomyocyte nuclei and 
plasma membranes were labeled with GFP and mKate, respectively (Figures 1B–1D and 
Figure S1A–S1H). This approach virtually eliminated the possibility of falsely counting cell 
aggregates as polyploid cardiomyocytes, which is a drawback of flow cytometric analysis. 
Nucleation analysis alone revealed that ~99% of cardiomyocytes in homeostatic hearts are 
mononucleated (Figure 1E), consistent with a previous report (Wills et al., 2008). DAPI-
fluorescence intensity was used to quantify the DNA contents of cardiomyocyte nuclei 
relative to a reference population of non-myocardial diploid cells (Figure S1I–S1Y). When 
plotted on a histogram, the distribution of cardiomyocyte ploidy, taking into account both 
nuclear number and DNA content (Figures 1F–1H), clustered into a single major peak that 
aligned with the diploid peak (Figure 1I). Altogether, this analysis revealed that ~99% of 
zebrafish cardiomyocytes are diploid (1x2c), whereas ~1% are polyploid with one (1x4c) or 
two (2x2c) nuclei (Figure 1K). Thus, in contrast to the non-regenerative polyploid hearts of 
adult mammals, the highly regenerative zebrafish myocardium is diploid, which further 
bolsters the inverse correlation observed between myocardial ploidy and regenerative 
capacity.
In adult mammals, a small number of cardiomyocytes surrounding infarcted myocardium re-
enter the cell cycle, undergo DNA replication, but largely fail to complete cytokinesis, which 
increases ploidy further (Ebert and Pfitzer, 1977; Senyo et al., 2013). To determine if cardiac 
injury induces myocardial polyploidization in zebrafish, we surveyed cardiomyocyte 
nucleation and ploidy both during (7 days post-resection; dpr) and after (60 dpr) heart 
regeneration. While the percentage of binucleated cardiomyocytes remained constant at both 
time points (Figure 1E), the proportion of mononucleated 4c cells increased at 7 dpr (Figures 
1J–1K), which we attribute to diploid cardiomyocytes cycling through G2 (Poss et al., 
2002). At 60 dpr, the percentage of mononucleated 4c cells remained elevated (Figure 1K), 
despite lowered cardiomyocyte proliferation at this stage (Poss et al., 2002). These data 
suggest that a small proportion of bona fide polyploid cardiomyocytes are created during 
regeneration. Nonetheless, they constitute only ~1% of the total population, demonstrating 
that successful cytokinesis, rather than polyploidization, is the predominant outcome of 
zebrafish cardiomyocytes entering the cell cycle during regeneration.
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We set out to test the hypothesis that doubling the DNA content of zebrafish cardiomyocytes 
would be sufficient to suppress their proliferative potential following injury. To that end, we 
sought an experimental tool to achieve transient inhibition of cardiomyocyte cytokinesis 
during cardiac growth, which occurs primarily by hyperplasia in zebrafish (Wills et al., 
2008). We searched the literature to identify dominant-negative proteins that were previously 
demonstrated to promote cytokinesis failure. We learned that dominant-negative forms of 
Racgap1, Kif23, or Ect2 are potent inhibitors of cytokinesis in cultured mammalian cells 
(Hirose et al., 2001; Liu et al., 2004; Tatsumoto et al., 1999). Racgap1 and Kif23 perform 
essential functions in central spindle formation. At the spindle, Ect2 catalyzes the conversion 
of RhoA-GDP to RhoA-GTP, which is required for contractile ring assembly and cytokinesis 
initiation (Green et al., 2012). Previous studies, using gene knockdown and knockout 
approaches, have demonstrated that Ect2 is essential for cytokinesis both in cultured cells 
and in several model organisms including zebrafish (Green et al., 2012; Hoijman et al., 
2015).
To determine whether racgap1, kif23, and ect2 are induced in proliferating cardiomyocytes, 
we performed qPCR on uninjured and regenerating hearts. We learned that all three genes 
are significantly upregulated at 7 dpr, with ect2 showing the strongest induction (Figure 1L), 
which persuaded us to evaluate its localization during regeneration. Using RNAScope in situ 
hybridization, we documented ect2 expression in cardiomyocytes along the wound edge 
(Figure 1M–1N) where proliferation is the highest (Sallin et al., 2015). These data are 
consistent with the notion that cardiomyocyte cytokinesis relies on Ect2 function in 
zebrafish.
Interestingly, by mining a publically available RNA-sequencing dataset (O’Meara et al., 
2015), we discovered that Ect2 expression declines in mouse neonatal cardiomyocytes 
(Figure S2) as they become polyploid (Alkass et al., 2015; Soonpaa et al., 1996) and the 
regenerative window closes (Porrello et al., 2011). This observation suggests that Ect2 
downregulation might be a natural mechanism to induce cardiomyocyte polyploidization in 
mammals.
Ect2 is required for zebrafish cardiomyocyte cytokinesis and for maintaining their diploid 
state
To learn if Ect2 is required for cardiomyocyte cytokinesis in zebrafish, we performed 
nucleation and ploidy analyses on cardiomyocytes from ect2 null-mutant embryos 
(Amsterdam et al., 2004) carrying the cmlc2:nucDsRed-Express transgene (Takeuchi et al., 
2011), which labels cardiomyocyte nuclei with red fluorescence. Using brightfield 
microscopy, we identified ect2 mutant embryos by their pronounced body curvatures, small 
heads and necrotic brains (Figure S3). To measure cardiomyocyte ploidy in these animals, 
we first determined nuclear number for individual cardiomyocytes in confocal Z-stacks 
using nuclear red fluorescence and a plasma membrane marker. We then quantified the 
ploidy of each nucleus based on DAPI fluorescence intensity. Compared to control siblings, 
mutant hearts at 30 hours post fertilization (hpf) contained a 2-fold increase in polyploid 
cardiomyocytes (Figures S4A–S4C). This difference grew to 9-fold at 72 hpf (Figures 2A, 
2B and 2D), which is soon after hyperplastic growth of the heart commences (Choi et al., 
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2013). These data demonstrate that proliferating zebrafish cardiomyocytes become polyploid 
in the absence of Ect2 activity.
Next, we tested whether a dominant negative Ect2 protein (dnEct2) would inhibit 
cytokinesis and induce polyploidization in cardiomyocytes during cardiac growth. Previous 
reports demonstrated that overexpression of a C-terminally truncated mouse ECT2 protein, 
which lacks the GEF catalytic domain but retains RhoA-GDP binding activity, behaves as a 
dominant negative protein (dnECT2) by interfering with the catalytic conversion of RhoA-
GDP to RhoA-GTP by wild-type ECT2 (Oceguera-Yanez, 2005; Sakata et al., 2000; 
Tatsumoto et al., 1999). We isolated and analyzed transgenic animals [Tg(cmlc2:GFP-P2A-
dnEct2), abbreviated cmlc2:GdnEct2] continuously expressing GFP and an analogously-
truncated zebrafish Ect2 protein (dnEct2) in all cardiomyocytes from embryonic stages. At 
72 hpf, transgenic embryos displayed a 6-fold increase in polyploid cardiomyocytes (Figures 
2C and 2D), a phenotype similar to that observed in ect2 mutants. To rule out perturbations 
in cell cycle entry caused by dnEct2 expression, we analyzed cardiomyocyte DNA synthesis 
and found no significant differences between cmlc2:GdnEct2 and sibling embryos (Figures 
S4D–S4F). During larval stages, cmlc2:GdnEct2 zebrafish were morphologically 
indistinguishable from siblings until 25 days post fertilization (dpf) (12.5 mm standardized 
standard length, SSL, Parichy et al., 2009) when their growth slowed, signs of heart failure 
emerged (Figure 2E), and survival plummeted (Figure 2F). An analysis of transgenic hearts 
at 30 dpf (14.5 mm SSL) revealed that ventricles of relatively normal size were composed of 
drastically fewer cardiomyocyte nuclei, 75% of which were polyploid with DNA contents 
ranging from 4c–16c (Figures 2G–2L). Cardiomyocyte diameter measurements revealed 
significant cellular hypertrophy (Figure S4G–S4I). These data demonstrate that continuous 
expression of dnEct2 expression in zebrafish cardiomyocytes impairs cytokinesis, induces 
polyploidization, and causes cells to grow by hypertrophy instead of hyperplasia. While 
tolerated initially, hypertrophic growth eventually becomes pathologic and heart failure 
ensures. We created these animals simply as a proof of concept that dnEct2 expression 
inhibits cardiomyocyte cytokinesis in zebrafish. They were not used for regeneration studies 
because ongoing experimental inhibition of cardiomyocyte cytokinesis after injury would 
mask any inherent proliferative potential polyploid cardiomyocytes might possess.
Design of a new transgenic system to create polyploid cardiomyocytes and track their 
contributions to regeneration
Therefore, we designed a double transgenic system, with two variations, to create adult 
zebrafish whose hearts contained cardiomyocyte populations that were: 1) significantly 
enriched in polyploid cells created by transient dnEct2 expression during cardiac growth and 
2) permanently labeled with GFP. The first variation caused only a subset of the myocardium 
to become GFP+ and polyploid enriched, which permitted a side-by-side comparison of the 
regenerative capacities of diploid and polyploid cardiomyocyte populations in the same 
hearts. The second caused the entire myocardium to become GFP+ and polyploid enriched, 
which significantly boosted the overall polyploid proportion and allowed us to evaluate the 
consequences for cardiac regenerative fitness.
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For the first variation, we generated the cmlc2:(iF-S)lox-mG transgene (Figure 3A), which 
contains a cardiomyocyte-specific promoter upstream of a “floxed” cassette for co-
expression of mOrange fluorescent protein and 4-HT-inducible Flipase. This cassette also 
contains a polyadenylation signal to prevent downstream transcription of a second cassette 
for Cre-dependent expression of membrane GFP (mG or GFP) in cardiomyocytes. Next, we 
generated the hsp:(P*-S)FRT-Cre-dnEct2 transgene (Figure 3B), which contains the zebrafish 
heat shock promoter upstream of a “blank” expression cassette flanked by FRT 
recombination sites. This cassette also contains a polyadenylation signal to prevent 
downstream transcription of a second expression cassette for Flipase-dependent heat shock-
mediated expression of Cre recombinase and dnEct2.
To create adult animals whose hearts were composed of GFP− diploid and GFP+ polyploid 
enriched cardiomyocyte populations, we treated 24 hpf double transgenic embryos with 4-
HT to induce Flipase-mediated excision of (P*-S) from the hsp:(P*-S)FRT-Cre-dnEct2 
transgene in a random subset of cardiomyocytes (Figures 3C and S5). Thereafter, this 
myocardial subset carried the recombined hsp:Cre-dnEct2 transgene, which conferred heat 
shock dependent co-expression of Cre recombinase and dnEct2. It also became permanently 
labeled with GFP following a single heat shock at 48 hpf, which induced Cre-mediated 
excision of (iF-S)lox from cmlc2:(iF-S)lox-mG to create cmlc2:mG. Animals were grown for 
3 weeks (up to ~10 mm SSL) at normal temperature to allow equivalent expansion of the 
GFP− diploid and GFP+ polyploid-susceptible cardiomyocyte populations through 
hyperplasia. Thereafter, animals were heat-shocked daily for 3 months to activate dnEct2 
expression, inhibit cardiomyocyte cytokinesis, and induce polyploidization specifically 
within the GFP+ subset. Next, we injured adult hearts by ventricular apex amputation and 
analyzed regeneration in the absence of heat shocking and experimental cytokinesis 
inhibition (Figure 3C).
Before injury, these animals and their hearts were grossly indistinguishable from controls 
(Figures 3D and 3E). Prominent subsets of GFP+ myocardium were present, in both the 
trabecular and compact layers (Figure 3E), indicating that transient expression of dnEct2 
during cardiac growth did not undermine cardiomyocyte viability. On average, 
approximately half of the myocardium was GFP+ in the mosaic hearts (50.28 ± 13.27 %, 
mean ± SD; Figure 3F, n=19).
Next, we assessed the efficiency of our experimental strategy for inducing cardiomyocyte 
polyploidization within the GFP+ subset of cardiomyocytes. We learned that approximately 
half of the GFP+ cardiomyocytes were polyploid with 4c DNA content, which represents an 
~50-fold enrichment over the native population (Figures 3G and 3H). The majority of the 
polyploid cardiomyocyte population was mononucleated (Figure 3H), similar to that in 
human hearts (Mollova et al., 2013; Sandritter and Adler, 1976). Given that ~50% of the 
myocardium was GFP+ (Figure 3F), and that ~50% of the GFP+ cardiomyocytes became 
polyploid (Figure 3G–3H), ~25% of the myocardium in mosaic hearts was polyploid. 
Importantly, GFP+ cardiomyocytes contained sarcomeres that were indistinguishable from 
neighboring cells (Figures 3I), ruling out a defect in cardiomyocyte differentiation. 
Polyploid cardiomyocytes in mosaic hearts were two times larger on average than their 
diploid counterparts (Figure 3I and 3J).
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The second variation of our transgenic system conferred polyploid susceptibility to the entire 
myocardium during cardiac growth. To that end, we replaced inducible Flipase with 
constitutive Flipase to generate cmlc2:(F-S)lox-mG (Figure 4A). After heat shocking double 
transgenic embryos once during embryogenesis (Figure 4B), the entire myocardium turned 
GFP+ (data not shown), indicative of homogeneous excision of (P*-S) from hsp:(P*-S)FRT-
Cre-dnEct2 to create hsp:Cre-dnEct2. After three weeks of growth without heat shock 
treatments followed by three months of daily heat shocking (Figure 4B), these animals and 
their GFP+ hearts were grossly indistinguishable from sibling animals not exposed to heat 
shocking during growth (Figures 4C and 4D). No evidence of DNA damage or apoptosis 
resulting from dnEct2 expression was detectable (Figures S6A–S6C and S6E–S6F). Control 
hearts were ~99% diploid (Figures 4E and 4F), indicating that polyploidization does not 
occur in the absence of heat shocking from transgene leakiness. Similar to the GFP+ 
population in partially enriched hearts (Figure 3F), approximately half of the homogenous 
GFP+ myocardium in heat-shocked animals was polyploid with 4c DNA content, with 
similar proportions containing one (1 × 4c) or two (2 × 2c) nuclei (Figures 4E and 4F).
Altogether, our two experimental strategies generated healthy adult zebrafish whose hearts 
contained a GFP+ cardiomyocyte population with approximately equivalent numbers of 
diploid and polyploid cardiomyocytes. In one strain, subsets of the myocardium were GFP+ 
and polyploid enriched (Figures 3A–3H). In the other strain, the entire myocardium was 
GFP+ and polyploid enriched (Figures 4A–4F). Importantly, we did not uncover evidence 
that cardiomyocyte polyploidization grossly undermines cellular (Figures 3E, 3I, 4D, S6A–
S6C, and S6E–S6F) or animal (Figures 3D and 4C) health when analyzed prior to cardiac 
injury. Moreover, inducing dnEct2 expression transiently for one week in homeostatic adult 
diploid myocardium did not elicit signs of toxicity including DNA damage (Figure S6D) or 
cell death (Figure S6G), suggesting that dnEct2 targets cytokinesis very specifically without 
impinging on multiple cellular processes. In this experiment, cardiomyocyte ploidy was not 
altered (Figure S6H–S6K) because cellular proliferation is minimal during homeostasis 
(Wills et al., 2008).
We studied regeneration in both strains following ventricular amputation. Importantly, 
animals were never heat shocked during the regenerative window. In other words, dnEct2 
expression and experimental cytokinesis inhibition were non-existent, which allowed us to 
monitor the inherent proliferative capacities of polyploid cardiomyocytes in an otherwise 
highly permissive environment in vivo.
Cardiomyocyte polyploidization is sufficient to impair regenerative proliferation
To evaluate the proliferative potential of polyploid cardiomyocytes relative to their diploid 
neighbors, we amputated ventricular apices of hearts containing subsets of GFP+ polyploid 
enriched cardiomyocytes (Figures 3C and 3E). After 45 days, we quantified the percentages 
of GFP+ polyploid enriched muscle in regenerated and surrounding myocardium. For each 
heart, we calculated a “GFP+ Cell Contribution Index” (GCCI), which represents the log2-
fold change in the percentage of GFP+ myocardium that occurred during proliferative 
expansion of wound-edge cardiomyocytes. A negative GCCI would reflect an impaired 
relative contribution made by GFP+ cells. To establish a baseline, we generated adult 
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animals whose hearts contained GFP+ “neutral” diploid cardiomyocytes by recombining 
cmlc2:(iF-S)lox-mG in a subset of embryonic cardiomyocytes with the cmlc2:CreERT2 
transgene (Kikuchi et al., 2010). These hearts regenerated normally (Figure 5A) and GFP+ 
diploid cells contributed robustly to regenerated muscle (Figure 5E). Next, we confirmed 
that FlpOERT2 was not leaky and that three months of daily heat shocking during growth did 
not impair regeneration in animals carrying unrecombined transgenes (Figure 5B). Lastly, 
we documented that a second population of “neutral” cardiomyocytes, those carrying the 
hsp:Cre-dnEct2 transgene but never exposed to heat shocking, contributed normally to 
regenerated muscle (Figures 5C and 5E).
When we injured hearts containing subsets of GFP+ polyploid-enriched myocardium, 
regeneration proceeded normally as evidenced by a lack of accumulated scar tissue (Figure 
5F). In the regenerated area, we observed a striking reduction in GFP+ cardiomyocytes 
(Figure 5D), which caused the GCCI to become significantly negative (Figures 5E). 
Importantly, BrdU incorporation analysis revealed that proliferation within the GFP+ 
polyploid enriched cardiomyocyte population was ~2-fold lower than that in the GFP− 
diploid fraction (Figures 5G–5I). Therefore, diploid cardiomyocytes outcompeted their 
polyploid neighbors in producing regenerated muscle through proliferative expansion, 
indicating that a single cytokinesis failure and resulting polyploidization during cardiac 
growth are sufficient to significantly reduce cardiomyocyte proliferation during 
regeneration.
Myocardial polyploidization creates a barrier to heart regeneration
During the course of analyzing regeneration of mosaic hearts containing a GFP+ polyploid-
enriched cardiomyocyte population, we observed scar formation instead of myocardial 
regeneration in a small number of hearts (Figure 6A, n=2). In these hearts, ~80% of the 
myocardium surrounding the injury area was GFP+. Therefore, the polyploid percentage 
was ~40% (~80% GFP+ myocardium × ~50% polyploid cells in enriched population= 
~40%). This observation suggested that the ploidy composition of wound edge myocardium 
might determine regenerative competence.
To pursue this observation further, we injured hearts with homogenous GFP expression and 
45% polyploid myocardium to determine if reducing the proportion of proliferation-
competent diploid cardiomyocytes from 99% to 55% would undermine regenerative 
potential. First, we documented normal regeneration in animals grown at normal 
temperature to rule out the possibility that injury alone would activate the hsp:Cre-dnEct2 
transgene (Figure 6B). Next, we learned that hearts composed of ~50% (45.04 ± 0.76 %, 
mean ± SD; Figure 4E) polyploid cardiomyocytes were incapable of completely 
regenerating and consistently scarred (Figure 6C). We found that the scar size in the 
polyploid-enriched hearts was 12-times bigger than that in control animals (Figure 6D). This 
was accompanied by a 61% reduction in BrdU incorporation between 7 dpr and 14 dpr 
(Figures 6E–6F and 6H). Importantly, heat shocking equivalent animals exclusively during 
adulthood, when the myocardium is minimally proliferative (Wills et al., 2008), did not 
undermine subsequent cardiomyocyte BrdU incorporation between 7 dpr and 14 dpr 
(Figures 6G and 6H), demonstrating that failed regeneration depends on dnEct2-mediated 
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polyploidization that occurs specifically during cardiac growth (Figures 4F and S6J). Taken 
together, these data demonstrate that the ploidy composition of the myocardium is a critical 
determinant of regenerative capacity.
Importantly, the myocardium in these hearts naturally upregulated endogenous Ect2 
following injury (Figure S7), which suggests that re-expression of Ect2 in polyploid 
cardiomyocytes is not sufficient to revert cardiomyocyte ploidy and that the proliferative 
barrier created by polyploidization is largely irreversible. This conclusion was further 
supported by the observation that overexpression of Ect2 in the highly polyploid 
myocardium of mice did not boost ventricular myocardial proliferation after experimental 
myocardial infarction (Figure S8).
DISCUSSION
Since the discovery of heart regeneration in zebrafish 15 years ago, substantial efforts have 
been expended to identify the signaling pathways required to initiate and achieve myocardial 
regeneration in this model organism (González-Rosa et al., 2017). However, it remains 
unclear whether the absence of cardiac regenerative potential in other vertebrate species, 
including adult mammals, can be ascribed to failed activation of pro-regenerative pathways, 
to cell-intrinsic properties that might prevent cardiomyocytes from participating in 
regeneration, or to a combination of both factors. To date, investigators have highlighted 
unique attributes of highly regenerative species as factors that might be permissive for 
cardiac regeneration. These include low blood pressure, hypoxic cardiac environment, low 
cardiac metabolic requirements, unique immune responses (Lai et al., 2017), and immature 
cardiomyocyte phenotypes including less organized sarcomeres and diploid DNA content 
(Vivien et al., 2016). Implicit in these arguments is that differing characteristics in non-
regenerative species represent barriers to cardiac regeneration. However, these simple 
correlations do not establish causality. In most cases, experimental evidence has not been 
provided to demonstrate that modifying these properties in a highly regenerative species is 
sufficient to dampen cardiac regeneration.
We took advantage of the highly regenerative zebrafish heart to study the potentially 
negative effect of polyploidization on myocardial regenerative potential. In this regard, we 
attempted to mimic the natural process of cardiomyocyte polyploidization that occurs from 
failed cytokinesis during post-natal life in mammals and correlates temporally with the loss 
of regenerative potential (Porrello et al., 2011). As designed, we attempted to isolate 
polyploidization as an initiating event in regenerative decline without directly modifying 
other properties of the zebrafish heart, which might contribute to the loss of regenerative 
potential in post-natal mice including immune system maturation (Lai et al., 2017), cardiac 
fibroblast expansion (Banerjee et al., 2007), elevated production of reactive oxygen species 
(Puente et al., 2014), and extracellular matrix alterations (Bassat et al., 2017).
Despite the notion that cardiomyocyte polyploidization might be synonymous with cell-
cycle exit, several counterexamples have been described in nature where polyploid cells re-
enter the cell cycle and divide robustly. This is the case for mammalian hepatocytes during 
liver growth and regeneration (Duncan et al., 2010) and for rectal papillar cells in Drosophila 
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(Fox et al., 2010). Moreover, polyploidization is required for regeneration of certain 
structures, such as the abdominal epithelium during Drosophila wound healing (Losick et 
al., 2013).
Recently, the percentage of mononuclear diploid cardiomyocytes in adult hearts of inbred 
mouse strains was reported to be variable and positively correlated with functional recovery 
after myocardial infarction (Patterson et al., 2017). Through genome wide association and 
genetic loss of function analyses, the authors identified TNNI3 interacting kinase (Tnni3k) 
activity as a positive regulator of myocardial polyploidization. Accordingly, continuous 
overexpression of Tnni3k in zebrafish cardiomyocytes elevated the percentage of 
mononuclear polyploid cardiomyocytes in adult animals from 0 to 7–20%, which correlated 
with compromised myocardial regeneration after amputation. While these data are consistent 
with a connection between myocardial polyploidization and reduced regenerative capacity, 
the potentially negative influence of a modest percentage of polyploid cardiomyocytes on 
heart regeneration in these animals cannot be disentangled from that of ongoing Tnni3k 
expression in spared cardiomyocytes (Vagnozzi et al., 2013). Lastly, this study was not 
designed to make direct comparisons between the regenerative capacities of diploid and 
polyploid cardiomyocytes as neither population carried a genetic label.
By establishing that the ploidy composition of zebrafish myocardium is diploid, we provided 
additional evidence to support the already-strong correlation between diploid myocardium 
and high regenerative capacity. To move beyond a correlation, we designed transgenic tools 
to transiently inhibit cytokinesis and induce cardiomyocyte polyploidization in zebrafish. To 
our knowledge, our experimental approach is unique in its ability to: 1) induce 
polyploidization through expression of dnEct2 exclusively in cardiomyocytes, without 
affecting other cell types; 2) enable lineage-tracking of polyploid enriched populations of 
cardiomyocytes during regeneration; and 3) discontinue dnEct2 expression during 
regeneration, which allowed us to assess the inherent proliferative capabilities of polyploid 
cardiomyocytes during heart regeneration. Importantly, our transgenic strategy allowed us to 
assess whether polyploidization resulting from cytokinesis failure, rather than dnEct2 
expression itself, creates a barrier to regeneration. This strategy is therefore superior to 
alternatives where a factor is expressed under a heat-shock promoter, which allows for 
temporal control but lacks tissue specificity, or where a factor is expressed from a 
myocardial specific promoter, which remains active following injury.
While the most obvious consequence of cytokinesis failure is the increase in DNA content, it 
is important to emphasize that a number of downstream changes are triggered in polyploid 
cells. These changes include increases in cell size, centrosome amplification, or metabolic 
alterations (Schoenfelder and Fox, 2015). Importantly, some of these changes are precisely 
some of the cell-intrinsic properties that might explain the differences between regenerative 
and non-regenerative hearts (Vivien et al., 2016). Nonetheless, identifying the molecular and 
cellular events downstream of polyploidization that impinge on myocardial regeneration will 
require further investigation.
By exploiting the ability of our transgenic system to generate mosaic hearts composed of 
GFP− diploid and GFP+ polyploid enriched populations, we learned that decreasing the 
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percentage of diploid cells in the GFP+ fraction, through polyploidization, caused 
quantitatively similar reductions in proliferation and contributions to regenerated muscle. 
Because these hearts were mosaic for the GFP+ population, the total percentage of polyploid 
myocardium was always less than 50% and regeneration was grossly unaffected. 
Remarkably, when we analyzed the regenerative potential of hearts containing >99% GFP+ 
myocardium, ~50% of which was polyploid, we observed a profound reduction in BrdU 
incorporation at 7 days post injury and scarring at later stages (Figure 7). Thus, while hearts 
composed of ~25% polyploid cardiomyocytes were able to regenerate, increasing the 
proportion to ~50% drastically reduced the regenerative ability of the zebrafish heart, 
suggesting that polyploid cardiomyocytes create a barrier to heart regeneration at a threshold 
within this range.
Further studies are required to understand why the substantial fraction (~50%) of diploid 
cardiomyocytes in these hearts did not support regeneration. One possibility is that diploid 
cardiomyocytes are endowed with a limited number cell divisions following injury. In 
agreement with this hypothesis, multicolor clonal analysis of the myocardium during 
zebrafish heart regeneration revealed that clones in the regenerated myocardium are 
composed of 2–4 cells, suggesting that cardiomyocytes along the wound edge divide 1–2 
times (Gupta et al., 2013). As a result, the percentage of diploid cells might become rate 
limiting when a large enough fraction of cardiomyocytes become proliferation-compromised 
by polyploidization. Any given maximal number of divisions might be determined by 
telomere erosion upon division. This hypothesis is consistent with the observation that 
telomerase reexpression and telomere expansion upon injury is required for heart 
regeneration in zebrafish (Bednarek et al., 2015). An alternative hypothesis is based on the 
relative locations of polyploid and diploid cardiomyocyte populations in the mosaic hearts. 
If the GFP+ border zone myocardium is preferentially enriched in polyploid cells, then 
diploid cardiomyocytes might not be able to actively invade the injured area and contribute 
to regeneration. Lastly, it remains possible that regenerative capacity is regulated by non-
autonomous signals released by diploid or polyploid cardiomyocytes that are pro- or anti-
regenerative, respectively. If true, then increasing the polyploid fraction would tip the 
balance towards lowered regenerative potential.
In summary, we transiently inhibited cytokinesis to induce polyploidization of zebrafish 
cardiomyocytes to mimic one aspect of the post-natal maturation of mammalian hearts. 
Although several factors have been hypothesized to impair heart regeneration in mammals 
(Vivien et al., 2016), our data provide compelling evidence that cytokinesis failure and 
polyploidization are the initiating events in the loss of regenerative potential. Myocardial 
polyploidization appears to have evolved at the expense of regenerative ability, perhaps as a 
mechanism to enhance organ growth or physiology. However, the specific advantages of 
cardiomyocyte polyploidization remain unknown. Lastly, our data provide rationale to better 
characterize rare diploid cardiomyocytes in mammalian hearts and devise therapies to 
stimulate their deployment for boosting natural heart regeneration in humans.
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STAR METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal anti-DsRed Clontech Cat#632496; RRID:AB_10013483
Mouse monoclonal anti-Dm-Grasp Developmental Studies 
Hybridoma Bank
Clone: Zn-8; RRID:AB_531904
Mouse monoclonal anti-BrdU ROCHE / Sigma-Aldrich Cat#BMC9318; RRID:AB_2313622
Mouse monoclonal anti-GFP Santa Cruz Biotechnology Cat#sc-9996; RRID:AB_627695
Chicken anti-GFP Aves Labs Cat#GFP-1010; RRID:AB_2307313
Rat monoclonal anti-BrdU Abcam Cat#ab6326 RRID:AB_305426
Mouse monoclonal anti-tropomyosin Developmental Studies 
Hybridoma Bank
Cat#CH1; RRID:AB_2205770
Rabbit polyclonal anti-Mef2 Santa Cruz Biotechnology Cat# sc-313; RRID:AB_631920
Rabbit polyclonal anti-gH2A.X phosphor-Ser139 GeneTex Cat# GTX50293; RRID:AB_11176141
Rabbit polyclonal anti-tRFP (mKate) Evrogen Cat# AB233 RRID:AB_2571743
Rabbit polyclonal anti-Ect2 Santa Cruz Biotechnology Cat# sc-1005 RRID:AB_2246263
Rabbit polyclonal anti-beta-galactosidase Molecular Probes Cat# A-11132; RRID:AB_221539
Mouse monoclonal anti-BrdU (for mouse experiments) Sigma-Aldrich Cat# 11585860001 (clone BMG6H8); 
RRID:AB_514485
Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 
488
Thermo Fisher Scientific Cat# A-11034; RRID:AB_2576217
Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 
555
Thermo Fisher Scientific Cat# A-21428; RRID:AB_2535849
Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary 
Antibody, Alexa Fluor 647
Thermo Fisher Scientific Cat# A-21244; RRID:AB_2535812
Goat anti-Chicken IgY (H+L) Secondary Antibody, Alexa 
Fluor 488
Thermo Fisher Scientific Cat# A-11039; RRID:AB_2534096
Goat anti-Mouse IgG1 Secondary Antibody, Alexa Fluor 488 Thermo Fisher Scientific Cat# A-21121; RRID:AB_2535764
Goat anti-Mouse IgG1 Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 568
Thermo Fisher Scientific Cat# A-21124; RRID:AB_2535766
Goat anti-Mouse IgG1 Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 647
Thermo Fisher Scientific Cat# A-21240; RRID:AB_2535809
Goat anti-Mouse IgG2a Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 488
Thermo Fisher Scientific Cat# A-21131; RRID:AB_2535771
Goat anti-Mouse IgG2a Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 555
Thermo Fisher Scientific Cat# A-21137; RRID:AB_2535776
Goat anti-Mouse IgG2a Cross-Adsorbed Secondary Antibody, 
Alexa Fluor 633
Thermo Fisher Scientific Cat# A-21136; RRID:AB_2535775
Chemicals, Peptides, and Recombinant Proteins
10% neutral buffered formalin Sigma-Aldrich Cat#HT501128
2,3-butanedione monoxime Sigma-Aldrich Cat#B0753
Accumax EMD Millipore Cat#SCR006
5-Bromo-2′-deoxyuridine (BrdU), zebrafish experiments EMD Millipore Cat#19-160
BrdU (for mice experiments) Roche Cat#280879
IGEPAL CA-630 Sigma-Aldrich Cat#I8896
González-Rosa et al. Page 13
Dev Cell. Author manuscript; available in PMC 2019 February 26.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
REAGENT or RESOURCE SOURCE IDENTIFIER
RQ1 RNase Free-DNAse Promega Cat#M6101
Tamoxifen Sigma-Aldrich Cat#T5648
Trizol Invitrogen Cat#15596-026
Trypsin / EDTA Gibco Cat#25200-056
Critical Commercial Assays
Direct-zol RNA MicroPrep kit Zymo Research Cat#R2062
Power SYBER Green PCR Master Mix Thermo Fisher Scientific Cat#4367659
RNAScope 2.5 HD Assay - RED ACD Cat#322350
SuperScript III First-Strand Synthesis System Thermo Fisher Scientific Cat#18080051
Click-iT™ Plus TUNEL Assay for In Situ Apoptosis 
Detection, Alexa Fluor™ 647 dye
Thermo Fisher Scientific Cat#C10619
Experimental Models: Organisms/Strains
Zebrafish: ect2 null: ect2hi3820aTg Amsterdam et al., 2004 ZFIN: ZDB-GENO-040831-2
Zebrafish: cmlc2:nucDsRed: Tg(cmlc2:nlsDsRed-Express)hsc4 Takeuchi et al., 2011 ZFIN: ZDB-GENO-110222-4
Zebrafish: cmlc2:mKate-CAAX: Tg(cmlc2:mKate-CAAX)sd11 Lin et al., 2012 ZFIN: ZDB-GENO-120320-1
Zebrafish: cmlc2:CreERT2: Tg(−5.1 cmlc2:CreERT2, 
cryaa:DsRed)pd10
Kikuchi et al., 2010 ZFIN ID: ZDB-GENO-120923-4
Zebrafish: ubi:Zebrabow: Tg(ubb:Zebrabow-M)a131 Pan et al., 2013 ZFIN ID: ZDB-GENO-150205-4
Zebrafish: cmlc2:nucGFP: Tg(cmlc2:nls-EGFP)fb18 This paper N/A
Zebrafish: cmlc2:GdnEct2: Tg(cmlc2:EGFP-P2A-dnEct2)fb19 This paper N/A
Zebrafish: cmlc2:(iF-S)lox-mG : Tg(cmlc2:loxP-nls-mOrange-
P2A-FlpOERT2-STOP-loxP-memGFP)fb20
This paper N/A
Zebrafish: cmlc2:(F-S)lox-mG : Tg(cmlc2:loxP-nls-mOrange-
P2A-FlpO-STOP-loxP-memGFP)fb21
This paper N/A
Zebrafish: hsp:(P*-S)FRT-Cre-dnEct2: Tg(hsp70l:FRT-
nucPhiYFP*-STOP-FRT-nlsCre-P2A-dnEct2; 
cryaa:ZsYellow)fb22
This paper N/A
Mouse: MHC-nLAC Soonpaa et al., 1994 N/A
Mouse: MHC-ECT2 This paper N/A
Oligonucleotides
Primers for cloning dnEct2:
For: 5′-ATGGCTGACAGCAGCATACT-3′
Rev: 5′-ACACAGCTTTCTTCATGGCAGG-3′
This paper N/A
qPCR primers, rps11
For: 5′-GATGGCGGACACTCAGAAC -3′
Rev: 5′-CCAATCCAACGTTTCTGTGA -3′
González-Rosa et al., 
2014
N/A
qPCR primers, ect2
For: 5′-GCAGCTCCACACTGGCTACT -3′
Rev: 5′-GGTGTGGTACTTTCTCTCAAAGG-3′
This paper N/A
qPCR primers, ect2 (splicing)
For: 5′-CGCCTAAACAAAAACACTGATTG -3′
Rev: 5′-GCCAGTGAGAAAGCAGTGAA -3′
This paper N/A
qPCR primers, kif23
For: 5′-CAGGGCATGGTCTCTGACA -3′
Rev: 5′-GCGTTTACCCTCCTCTCACA -3′
This paper N/A
qPCR primers, racgap1
For: 5′-GCCTTCCTCATCATCCATCT -3′
For: 5′-TGTGGGTCCAAATACACGAG -3′
This paper N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
Recombinant DNA
MDR1734-202791320 (Danio rerio ect2) GE Dharmacon Cat# MDR1734-202791320
MMM4769-202769099 (Mus musculus ect2) GE Dharmacon Cat# MMM4769-202769099
p5E-hsp70l Kwan et al., 2007 N/A
pAAV-pgk-Cre Gift from Patrick 
Aebischer
Addgene Cat#24593
pBS-FlpOER Lao et al., 2012 N/A
pThy1-Brainbow3.2 Cai et al., 2013 Addgene Cat#45179
Software and Algorithms
Fiji/ImageJ NIH RRID:SCR_002285
GraphPad Prism 7 GraphPad Software N/A
NIS-Elements Nikon Instruments N/A
Other
4′,6-diamidino-2-phenylindole dihydrochloride Invitrogen Cat#D1306
FluorSave Reagent Calbiochem Cat#345789
Hoechst 33342 ThermoFisher Scientific Cat#H3570
Mouse-on-Mouse kit Vector Cat#BMK-2202
Osmotic mini-pumps Alzet Cat#1002
RNAscope probe Dr-ect2 ACD Cat#472701
RNAscope probe Dr-ect2-O1 ACD Cat#504041
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Geoffrey C. Burns (gburns@cvrc.mgh.harvard.edu).
EXPERIMENTAL MODELS AND SUBJECT DETAILS
Zebrafish—Zebrafish embryos, larvae, and adults were produced, grown, and maintained 
according to standard protocols approved by the Institutional Animal Care and Use 
Committees of Massachusetts General Hospital. Ethical approval was obtained from the 
Institutional Animal Care and Use Committees of Massachusetts General Hospital. For 
experiments with adult zebrafish, animals ranging in age from 3 to 18 months were used. 
Approximately equal sex ratios were used for experiments. Adult density was maintained at 
~3–4 fish·l−1 for all experiments in Aquarius racks and fed three times daily. Water 
temperature was maintained at 28 °C except during heat shock treatments.
Published strains used in this study include: wild-type AB, ect2 mutants (ect2)hi3820aTg 
(Amsterdam et al., 2004), Tg(cmlc2:nlsDsRed-Express)hsc4 (Takeuchi et al., 2011), 
Tg(cmlc2:mKate-CAAX)sd11 (Lin et al., 2012), Tg(−5.1 cmlc2:CreERT2, cryaa:DsRed)pd10 
(Kikuchi et al., 2010), Tg(ubb:Zebrabow-M)a131 (Pan et al., 2013). Details of the 
construction of the new lines generated in this study are described below. At least three 
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independent founders of each line were isolated and tested to confirm the described 
expression patterns and phenotypes. Transgene sequences are available upon request.
Mice—Experimental mice were generated in an inbred DBA/2J background. Animals were 
housed under a 14-h light, 10-h dark cycle in the Laboratory Animal Research Center at the 
Indiana University Medical School. Experiments were initiated when mice reached 12 
weeks of age. Animals were provided food and water ad libitum. All mice treatment, 
surgery, and euthanasia protocols utilized in this study were performed in accordance with 
National Institutes of Health Guidelines and were approved by the Institutional Animal Care 
and Use Committee (Study #10881). All surgeries were performed under isoflurane 
anesthesia, and all efforts were made to minimize suffering.
METHOD DETAILS
Ect2 mutant genotyping—The ect2hi3820aTg allele consists of a retroviral insertion in the 
first intron of ect2 that interrupts the expression of the gene (Figure S3). Heterozygous 
animals carrying the ect2hi3820aTg allele were identified by PCR using the primers 5′-
CGCTTCTCGCTTCTGTTCG-3′ and 5′-GACATTGTGGAAGGAAGACACG-3′. Because 
the first primer anneals in the retroviral sequence, animals carrying the mutant allele 
produced a 471 bp amplicon.
Construction of cmlc2:nucEGFP—To generate the cmlc2:nucEGFP transgenic line, a 
construct containing the following DNA elements was assembled by Gibson cloning: (1) a 
~0.9-kb cmlc2 promoter to drive specific expression in cardiomyocytes; (2) the coding 
sequence for a nuclear localized enhanced green fluorescent protein (nls-EGFP). The entire 
construct was flanked with Tol2 sites to facilitate transgenesis. In this line, all 
cardiomyocytes constitutively express nls-EGFP. The full name of this line is Tg(cmlc2:nls-
EGFP)fb18.
Construction of cmlc2:GdnEct2—To generate the cmlc2:GdnEct2 transgenic line, a 
construct containing the following DNA elements was assembled by Gibson cloning: (1) a 
~0.9-kb cmlc2 promoter to drive specific expression in cardiomyocytes; (2) a bicistronic 
cassette encoding EGFP and a truncated version of Danio rerio ect2 containing the first 337 
amino acids (amplified from clone MDR1734-202791320, GE Dharmacon, using the 
primers 5′-ATGGCTGACAGCAGCATACT-3′ and 5′-
ACACAGCTTTCTTCATGGCAGG-3′), separated by a P2A sequence (Kim et al., 2011). 
Expression of similar truncations have been described in mammals to strongly inhibit 
cytokinesis due to the lack of GEF activity (Oceguera-Yanez, 2005; Sakata et al., 2000; 
Tatsumoto et al., 1999). The entire construct was flanked with Tol2 sites to facilitate 
transgenesis. In this line, all cardiomyocytes constitutively express a dominant negative form 
of Ect2 and the fluorescent protein EGFP. The full name of this line is Tg(cmlc2:EGFP-
P2A-dnEct2)fb19.
Construction of cmlc2:(iF-S)lox-mG zebrafish—To generate the cmlc2:(iF-S)lox-mG 
transgenic line, a construct containing the following DNA elements was assembled by 
Gibson cloning: (1) a ~0.9-kb cmlc2 promoter to drive specific expression in 
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cardiomyocytes; (2) a floxed bicistronic nls-mOrange2-P2A-FlpOERT2-polyA cassette that 
was generated by subcloning mOrange2 from pThy1-Brainbow3.2 (Addgene #45179, (Cai 
et al., 2013)) and FlpOERT2 from pBS-FlpOER (kindly provided by Drs. Lao and Joyner 
(Lao et al., 2012)); and (3) a GFP containing a farnesylation tag to direct the fluorescent 
protein to the cell membrane (subcloned from pThy1-Brainbow3.2). The entire construct 
was flanked with Tol2 sites to facilitate transgenesis. In this line, all cardiomyocytes express 
the fluorescent protein mOrange2 directed to the nucleus and a tamoxifen-inducible Flipase. 
Upon Cre mediated recombination, the floxed cassette is eliminated and cardiomyocytes 
(and those cardiomyocytes that derive from them) are permanently labeled by the expression 
of a membrane-tagged GFP (Figure S5). The full name of this line is Tg(cmlc2:loxP-nls-
mOrange-P2A-FlpOERT2-STOP-loxP-memGFP)fb20.
Construction of cmlc2:(F-S)lox-mG zebrafish—To generate the cmlc2:(F-S)lox-mG 
transgenic line, the cmlc2:(iF-S)lox-mG construct was modified by Gibson cloning as 
follows: (1) the bicistronic nls-mOrange2-P2A-FlpOERT2-polyA cassette was substituted 
with a nls-mOrange2-P2A-FlpO in which the recombinase lacks the ERT2 domain and is 
therefore constitutively active; and (2) a woodchuck hepatitis virus posttranscriptional 
regulatory element (WPRE) – Xenopus β-globin polyadenylation signal cassette was added 
downstream of the FlpO to increase transcript stability. In this line, all cardiomyocytes 
express the fluorescent protein mOrange2 directed to the nucleus and a constitutively active 
Flipase. Upon Cre mediated recombination, the floxed cassette is eliminated and 
cardiomyocytes (and those cardiomyocytes that derive from them) are indelibly labeled by 
the expression of a membrane-tagged GFP. The full name of this line is Tg(cmlc2:loxP-nls-
mOrange-P2A-FlpO-STOP-loxP-memGFP)fb21.
Construction of hsp:(P*-S)FRT-Cre-dnEct2 zebrafish—To generate the hs:(P*-
S)FRT-Cre-dnEct2 transgenic line, a construct containing the following DNA elements was 
assembled by Gibson cloning: (1) a ~1.5-kb hsp70l promoter to drive expression in response 
to heat shock (Halloran et al., 2000), amplified from p5E-hsp70l (Kwan et al., 2007); (2) the 
coding sequence of a Y65A mutated version (non fluorescent) of the fluorescent protein 
PhiYFP amplified from pThy1-Brainbow3.2 (Cai et al., 2013) flanked by FRT sites; (3) a 
bicistronic nls-Cre-P2A-dnEct2 cassette generated by subcloning a codon optimized, nuclear 
directed Cre from pAAV-pgk-Cre (a gift from Patrick Aebischer, Addgene plasmid #24593) 
and the Danio rerio dnEct2 amplified from cmlc2:GdnEct2. A cryaa:ZsYellow transgenesis 
control was included in the opposite orientation to facilitate visualization of transgenic 
animals. The entire construct was flanked with Tol2 sites to facilitate transgenesis. In this 
line, cells express PhiYFP* only after heat shock. Upon Flipase mediated recombination, the 
FRT-flanked cassette is eliminated and cells exposed to heat shock then express nls-Cre and 
dnEct2 (Figure S5). The full name of this line is Tg(hsp70l:FRT-nucPhiYFP*-STOP-FRT-
nlsCre-P2A-dnEct2; cryaa:ZsYellow)fb22.
Generation of MHC-ECT2 mice—The MHC-ECT2 transgene used the mouse alpha-
cardiac myosin heavy chain (MHC) promoter and sequences encoding Mus musculus ECT2 
(amplified from clone MMM4769-202769099, GE Dharmacon). The SV40 early region 
transcription terminator/poly-adenylation site (nucleotide residues #2586-2452) was inserted 
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downstream from the ECT2 sequences. Transgene insert was purified and microinjected into 
inbred C3HeB/FeJ (Jackson Laboratories, Bar Harbor MA) zygotes as described (Soonpaa 
et al., 1994). The resulting pups were screened using diagnostic PCR amplification and 
transgenic lineages were established. Transgene expression was stratified initially via qPCR 
and then confirmed by anti-Ect2 immunofluorescence (Figure S8).
Zebrafish Cardiac Injuries—Regeneration experiments were conducted using adult 
zebrafish as described (Poss et al., 2002). Briefly, fishes were anesthetized in tricaine, placed 
with their ventral side up on a sponge and a small incision was created to expose the apex of 
the ventricle. Approximately 20% of the ventricle was amputated using iridectomy scissors. 
A Kimwipe was applied to the bleeding animal with gentle pressure for a few seconds, and 
the animals were retrieved to a fish tank. After surgery, animals were revived by gently 
directing water to their gills using a plastic Pasteur pipette.
Myocardial infarction and cardiomyocyte DNA synthesis assay in mouse—
MHC-ECT2 line 1 mice were crossed with MHC-nLAC mice (Soonpaa et al., 1994), which 
express a nuclear cardiomyocyte-restricted β-galactosidase reporter to assist in 
cardiomyocyte nuclear identification in tissue sections. MHC-ECT2; MHC-nLAC double 
transgenic mice and MHC-nLAC single transgenic mice were intubated and ventilated with 
2% isoflurane and supplemental oxygen. Via left thoracotomy, the left coronary artery was 
ligated at the inferior border of the left auricle as described previously (Murry et al., 2004). 
The mice were then implanted with osmotic mini-pumps (Alzet #1002; Cupertino, 
California) containing bromodeoxyuridine (16 mg/ml in phosphate buffered saline (PBS); 
Roche, #280879; Indianapolis, Indiana) as described (Soonpaa and Field, 1994). Tissues 
were harvested, fixed in cacodylic acid/ paraformaldehyde as described (Soonpaa and Field, 
1997), and then cryoprotected in 30% sucrose in PBS, and sectioned at 10 microns using 
standard methodologies. After antigen retrieval (30 minute incubation in sodium citrate 
buffer at 100°C), samples were processed for β-galactosidase (Invitrogen Lifetechnologies 
#A-11132) and BrdU (Roche #11296736001; clone BMG 6H8 IgG1) immune reactivity 
using the Vector Mouse-on-Mouse kit (#BMK-2202). Signal was developed using Alexa 
555-conjugated goat anti-rabbit and Alexa 488-conjugated goat anti-mouse secondary 
antibodies (Invitrogen Lifetechnologies #A21429 and #A11001, respectively). DNA was 
visualized with Hoechst 33342 (Invitrogen Lifetechnologies).
Tamoxifen and heat shock treatments—To induce Flipase-ERT2 mediated 
recombination, 24–30 hours post-fertilization (hpf) zebrafish larvae were exposed to 10 μM 
4-hydroxy-tamoxifen (4-OHT, Sigma) for 12 hours. Treated embryos were washed in E3, 
raised to adulthood and used in the experiments described below. For mosaic experiments, 
embryos with highly recombined hearts were selected for growing. Heat-shock induction 
was conducted by placing embryos into a 39 °C water bath for 1 hour. When required, ~2–3 
weeks post fertilization animals were transferred to an automated heat shock rack that 
exposed them daily to 60 minute elevations in temperature from 28 °C to 39 °C, as described 
(Lee et al., 2005). Adult heat shock treatments were performed using the same system.
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Cardiomyocyte isolation from zebrafish ventricles—To generate single cell 
suspensions, zebrafish hearts were dissected as described previously (González-Rosa and 
Mercader, 2012) using ice-cold PBS supplemented with 0.3% bovine serum albumin (BSA, 
A3059, Sigma) and 20 mM glucose (G7528, Sigma) as dissection buffer. Hearts were 
collected in a 3 ml Petri Dish (153066, ThermoFisher Scientific) maintained on ice. After 
removing the atrium and the bulbous, ventricles were bisected to wash out any remaining 
blood. Tissues then were washed twice in dissection buffer and treated for 15 min in a 
solution of 0.2% trypsin, 0.8 mM EDTA (25200-056, Gibco) supplemented with 20 mM 
glucose and 10 mM 2,3-butanedione monoxime (B0753, Sigma). The first digestion was 
performed on ice and using gentle agitation. Next, the digestion solution was removed, the 
ventricles were washed three times using dissection buffer supplemented with 10 mM BDM 
and then digested for 45 min at room temperature in Accumax (SCR006, EMD Millipore) 
supplemented with 20 mM glucose and 10 mM BDM under mild agitation. Tissue fragments 
were dissociated by gentle pipetting and cell suspensions were immediately fixed in 10% 
neutral buffered formalin (HT501128, Sigma) for 1 hour at room temperature. Cells were 
pelleted by centrifugation at 400 × g for 5 minutes, resuspended in PBS, spread in Superfrost 
Plus slides (1255015, ThermoFisher Scientific) and air dried.
DNA quantification in cell spreads—DNA content was determined by quantifying the 
integrated nuclear density of cells stained with the DNA dye 4′,6-diamidino-2-phenylindole 
(DAPI), by adapting preexisting protocols (Ikenishi et al., 2012; Roukos et al., 2015; Tane et 
al., 2014). Briefly, cardiomyocyte spreads were rehydrated in PBS, permeabilized for 45 
minutes in 0.1% IGEPAL CA-630 (I8896, Sigma), 3% BSA in PBS and stained for 30 min 
using 14.3 μM DAPI dihydrochloride (Invitrogen) in permeabilization solution. After 
washing in PBS, slides were mounted in FluorSave Reagent (345789, Calbiochem) and 
images were acquired using a Nikon 80i compound microscope (Nikon Instruments) with a 
20x lens, a Retiga 2000R high/speed CCD camera (QImaging) and the NIS-Elements image 
acquisition and analysis system (Nikon Instruments).
For each field (592 μm × 444 μm), fluorescence was captured from adequate channels (e.g. 
red for mKate-CAAX and/or mCherry, green for nucGFP and blue for DAPI) and saved 
independently as 12-bit *.nd2 files. Individual channels were merged in ImageJ software 
(Schneider et al., 2012), exported as a composite *.tiff file and binary masks containing 
nuclear areas, based on the blue channel (DAPI), were generated manually in Adobe 
Photoshop (Adobe Systems Incorporated). Only intact cells were analyzed and isolated 
nuclei or damaged cells were excluded. Independent binary masks were generated according 
to the expression of fluorescent proteins to distinguish cell populations.
Masks were then processed using the ROI Manager tool of ImageJ and the following macro:
run(“RGB Color”);
run(“8-bit”);
setAutoThreshold(“Default”);
//setThreshold(0, 200);
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setOption(“BlackBackground”, false);
run(“Convert to Mask”);
run(“Analyze Particles…”, “display exclude clear add”);
run(“Flatten”);
that allowed to recognize individual nuclei and to generate a copy of the binary mask with 
each nucleus receiving a number for further reference. Integrated density from each nucleus 
was then calculated using the Multimeasure tool in ImageJ in the original 12-bit *.nd2 DAPI 
image. Values were exported and collected in an Excel file.
Ploidy measurement in dissociated cardiomyocytes—Ploidy values were 
determined on a per-nucleus basis by using the following strategy (Figure S1): First, the 
average raw integrated density value from a reference cell population (i.e., uninjured 
cardiomyocytes expressing a distinctive fluorescent protein) was determined for every 
picture. Then, the integrated density value from each cell from the same picture was divided 
by the average value of the control population and multiplied by 2. Additionally, images 
were manually inspected to determine the presence of binucleated cells. To that end, binary 
masks were compared to images containing membrane labeling (i.e., mKate-CAAX) (Figure 
S1). In the case of binucleated cells, values from both nuclei were then added in Excel. 
Ploidy values were then transferred to GraphPad Prism 7 to generate frequency histograms 
using a bin size of 0.25c. As a consensus based on the reference population, we considered 
diploid “2c”, those cells with values between 1.25c and 2.75c.
Quantification of cardiomyocyte nucleation in adult zebrafish—Cardiomyocyte 
nucleation was scored manually using cell spreads counterstained with DAPI as described 
above. To efficiently distinguish bona fide binucleated cells from cell aggregates, 
cardiomyocytes were isolated from animals carrying a transgene that directed the expression 
of a fluorescent protein to the cell membrane (i.e., cmlc2:mKate-CAAX or cmlc2:mGFP) 
(Figure S1).
Quantification of cardiomyocyte nucleation and ploidy in zebrafish 
cardiomyocytes—Cardiomyocyte nucleation was analyzed in ect2 mutant, 
Tg(cmlc2:GdnEct2) and sibling embryos carrying the Tg(cmlc2:nlsDsRed-Express) 
transgene. Embryos were fixed at 30 and 72 hpf overnight in 4% paraformaldehyde (PFA) in 
PBS at 4°C. Fixed embryos were bleached and permeabilized as described (Jahangiri et al., 
2016), and subjected to immunofluorescence staining with anti-DsRed (Clontech, 1:200) 
and anti-Alcama (Dm-Grasp, clone Zn-8, Developmental Studies Hybridoma Bank; 1:50) 
antibodies. Alexa conjugated secondary antibodies (Life Technologies, 1:500) were used to 
detect primary antibody signals. Nuclei were counterstained with DAPI. Stained embryos 
were mounted in low-melting agarose and imaged using a Nikon A1 confocal microscope 
equipped with a 40X water immersion lens. Hearts of stained embryos were imaged and 
analyzed using ImageJ software. To estimate cardiomyocyte nucleation, the number of 
DsRed+ nuclei per cardiomyocyte (whose borders were Almcam+) were quantified. Nuclear 
ploidy was calculated based on DAPI integrated density as described above and compared to 
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non-cardiomyocyte populations present in the same optical sections. Cardiomyocyte ploidy 
combines both nucleation and nuclear ploidy analysis.
Analysis of cardiomyocyte proliferation in zebrafish embryos—Zebrafish 
embryos were incubated in 5 mg/ml BrdU, 1% DMSO in E3 medium from 48 hpf to 72 hpf 
at 28°C, rinsed three times i n E3 medium and fixed overnight in 4% PFA. Fixed embryos 
were rinsed in PBST, bleached in the dark for 20 min (using 0.8% KOH, 0.9% H2O2 and 
1% Tween-20 in distilled water), permeabilized using 1% Triton-X100 in PBS for 2 h and 
equilibrated in DNase I buffer (40 mM Tris-HCl, pH 8.0, 10 mM MgSO4, 1 mM CaCl2) for 
30 min at 37°C. Equili brated embryos were treated with DNase I (1:50 in equilibration 
buffer) for 2 h at 37°C, rinsed three times in PBSTw (PBS+0.1% Tween20) and subjected to 
immunofluorescent staining with anti-GFP (clone B-2, Santa Cruz Biotechnology; 1:200) 
and anti-BrdU (clone BMC9318, Roche; 1:100) antibodies. The ventricles of stained 
embryos were imaged and analyzed as described above. A ventricular proliferation index 
(number of BrdU+, GFP+ double positive cells divided by the total number of GFP+ 
cardiomyocytes) was manually calculated for each embryo using ImageJ and averaged.
Zebrafish histological analysis and imaging—Adult zebrafish were euthanized by 
immersion in 0.16% tricaine (Sigma) and hearts dissected as described (González-Rosa and 
Mercader, 2012). Samples were fixed overnight at 4°C in 4% PFA, included in paraf fin and 
sectioned following conventional histological procedures.
To detect ect2 transcripts, RNAscope (Advanced Cell Diagnostics) was performed on 7 μm 
paraffin sections following the manufacturer’s instructions. Advanced Cell Diagnostic 
designed an ect2 probe spanning nucleotides 859-1756. Following ect2 detection, sections 
were incubated overnight with anti-tropomyosin or GFP antibodies (see below) and nuclei 
were counterstained using DAPI. To confirm ect2 re-expression in polyploid-enriched hearts 
(Figure S7), a new probe spanning nucleotides 1920-2835 of ect2 NM_001003883.1 was 
generated to avoid cross-reaction with dnEct2 sequence.
Immunofluorescence and TUNEL in paraffin sections were performed as described 
(González-Rosa et al., 2011). Primary antibodies used were mouse anti-tropomyosin (clone 
CH1, Developmental Studies Hybridoma Bank; 1:50), chicken anti-GFP (AVES, 1:500), 
mouse anti-GFP (clone B-2, Santa Cruz Biotechnology; 1:200), rabbit anti-Mef2 (clone 
C-21, Santa Cruz Biotechnology; 1:100), rat anti-BrdU (ab6326, Abcam; 1:100), mouse 
anti-BrdU (clone BMC9318, Roche; 1:100), rabbit anti-γH2A.X phospho-Ser139 
(GTX127342, GeneTex; 1:100), rabbit anti-mKate (AB233, Evrogen; 1:500) and rabbit anti-
Ect2 (clone C-20, Santa Cruz Biotechnology; 1:100). Alexa conjugated secondary antibodies 
(Life Technologies, 1:500) were used to detect primary antibody signals. Nuclei were 
counterstained with DAPI and slides were mounted in FluorSafe. A Nikon A1 confocal 
microscope was used to image immunostained sections.
Acid fuchsin-orange G (AFOG) stain was used to detect fibrotic tissue. Muscle, fibrin/cell 
debris and collagen were stained brown-orange, red and blue, respectively.
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BrdU pulse-chase experiments during zebrafish heart regeneration—For BrdU 
pulse-chase experiments (Figures 5G–5I and 6D–6G), adult zebrafish were used to perform 
apical ventricular resection. At 7 dpr, animals were injected intraperitoneally with 50 μl of 
2.5 mg/ml, at 7 days post-resection (dpr), and hearts were extracted and processed for 
analysis at 14 dpr. To calculate BrdU cardiomyocyte labeling indices, ventricular sections 
were immunostained with anti-Mef2, anti-GFP, anti-Tropomyosin and anti-BrdU antibodies 
(see above). 2–3 ventricular sections containing the largest injury areas were imaged. Mef2+, 
GFP+Mef2+BrdU+ and GFP−Mef2+BrdU+ cells were counted manually using ImageJ 
software in defined regions (200 μm × 424.55 μm) that include the injury area and border 
zone. The percentages of GFP+Mef2+BrdU+/Mef2+ and GFP−Mef2+BrdU+/Mef2+ cells 
from individual sections were averaged to establish a BrdU labeling index for each animal.
Quantification of GFP+ contribution to regeneration—To quantify the percentage 
of regenerated myocardium occupied by cells expressing EGFP, histological sections 
containing regenerated muscle from each heart were systematically identified and analyzed. 
Every heart was sectioned in its entirety and pairs of consecutive sections were repeatedly 
distributed across the same five slides. As a result, five slides were created for every heart 
that contained equally spaced sections across the entire organ. For each heart, one slide was 
stained with AFOG and all sections were carefully examined under the microscope. 
Regenerated regions of muscle were identified in sections as localized thickenings of dense 
muscle containing evidence of residual fibrosis (blue) when compared to surrounding 
compact muscle. Next, a slide containing adjacent pairs of sections was immunostained with 
antibodies to recognize GFP and tropomyosin as described above. Guided by which 
section(s) contained regenerated muscle on the AFOG-stained slide, an adjacent section was 
identified on the immunostained slide. In that section, the location of regenerated muscle 
was identified as a localized thickening of dense muscle, which showed signs of myocardial 
disarray. This section was imaged by confocal microscopy as described elsewhere. In 
photoshop, three regions of 140 μm × 140 μm were defined. This region size was empirically 
determined to encompass the entire regenerated area in all cases. The middle region was 
centered over the regenerated muscle. Two adjacent, non-overlapping regions were aligned 
laterally on either side to define regions of spared muscle. The EGFP+ and tropomyosin+ 
areas were quantified in pixels for each region, and the percentage of EGFP versus 
tropomyosin was calculated. The average value of EGFP+/tropomyosin+ was calculated for 
the uninjured regions. To calculate the relative change in proportion of GFP between the 
regenerate and the surrounding area, the following expression was used: 
log2(%GFPregenerate/%GFPsurrounding).
Quantification of fibrotic tissue in regenerated hearts—To quantify the fibrotic 
area in regenerated hearts at 45 dpr, images of evenly-spaced AFOG-stained serial sections 
of the whole heart were captured using a Nikon 80i compound microscope (Nikon 
Instruments) with a 4x lens and a mounted Excelis AU600HDS HD Camera (Accu-Scope 
Inc. Commack, NY). On average, ~21 sections were analyzed per heart (min=13, max=30; 
1427 total sections analyzed). Masks containing the entire ventricular area and the scar area 
were manually generated using Adobe Photoshop based on differential staining (uninjured/
regenerated muscle=brown/orange; fibrotic area=(fibrin (red) + collagen (blue)). Selected 
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areas were measured using ImageJ software. As described previously (Chablais et al., 2011; 
Schnabel et al., 2011), the fibrotic area was normalized to the total ventricular area to 
calculate the percentage of the scar size for each heart.
Quantitative real-time PCR—RNA from cardiac ventricles or zebrafish larvae was 
extracted using Trizol reagent (Life Technologies) and the Direct-zol RNA MicroPrep kit 
(Zymo Research). For adult expression experiments (Figure 1L), 1 ventricle was used per 
biological replicate and 10 biological replicates were analyzed per time point. For 
embryonic expression (Figure S3), 10-pooled control or mutant embryos were used per 
biological replicate. 6 biological replicates were analyzed. RNA was transcribed to cDNA 
using the SuperScript III First-Strand Synthesis System (Life Technologies). qRT-PCR was 
performed using Power SYBER Green PCR Master Mix (Applied Biosystems, Life 
Technologies). Expression of genes was normalized with the arithmetic mean of the 
expression level of the constitutive gene rps11 as described (González-Rosa et al., 2014). A 
complete list of the primers used in this study is provided in the Key Resources Table.
QUANTIFICATION AND STATISTICAL ANALYSIS
Sample sizes were chosen based on previous publications and are indicated in each figure 
legend. No animal or sample was excluded from the analysis unless the animal died during 
the procedure. The experiments were not randomized, and the investigators were not blinded 
to allocation during experiments and outcome assessment. All statistical values are displayed 
as mean ± standard deviation. Sample sizes, statistical test and P values are indicated in the 
figures or figure legends. Data distribution was determined before using parametric or non-
parametric statistical test. Statistical significance was assigned at P < 0.05. All statistical 
tests were performed using Prism 7 software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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HIGHLIGHTS
• Cardiomyocytes in adult zebrafish are predominantly mononucleated and 
diploid.
• Transient inhibition of Ect2 induces polyploidization of zebrafish 
cardiomyocytes.
• Diploid cardiomyocytes outcompete polyploid cardiomyocytes during heart 
regeneration.
• Hearts composed of >45% polyploid cardiomyocytes fail to regenerate.
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Figure 1. Zebrafish cardiomyocytes are mononucleated, diploid, and upregulate Ect2 during 
heart regeneration
(A) Schematic depicting cardiomyocyte nucleation and ploidy. See also Figure S1. (B) 
Cardiomyocytes (white arrows) from dissociated Tg(cmlc2:nucGFP) hearts. (C,D) 
Mononucleated and binucleated Tg(cmlc2:nucGFP) cardiomyocytes. (E) Average 
percentages of mononucleated (MonoN) and binucleated (BiN) cardiomyocytes in uninjured 
(UI), 7 dpr and 60 dpr ventricles (mean±s.d., n=9309, 9269, 9578 total cells respectively 
from 4 biological replicates per group; 2 pooled ventricles per replicate; n.s., not significant 
by one-way ANOVA test). (F,H) DAPI-stained mononucleated diploid, binucleated 
tetraploid, and mononucleated tetraploid cardiomyocytes isolated from Tg(cmlc2:nucGFP) 
hearts. Insets show DAPI signal. (I) Distributions of non-cardiomyocyte (gray) and 
cardiomyocyte (green) DNA content in homeostatic ventricles (n=779 and 552 cells, 
respectively, from 3 biological replicates; 1 ventricle per replicate). (J) Distributions of 
cardiomyocyte DNA content in 7 dpr and 60 dpr ventricles (blue and orange bars, 
respectively; overlap appears in brown). Insets are magnifications to show low frequency 
events (black arrows, tetraploid cardiomyocytes). (K) Quantification of indicated 
cardiomyocyte populations from UI, 7 dpr and 60 dpr ventricles (mean±s.d., n=3250, 2699 
and 4306 total cells from 7, 3 and 4 biological replicates per group, respectively; 3 ventricles 
per replicate; ****P<0.0001; **P<0.01 by one-way ANOVA followed by Tukey’s multiple 
comparisons test). (L) qPCR analysis showing relative expression of three genes involved in 
cytokinesis in UI, 7 dpr, and 60 dpr ventricles (mean±s.d, n=3 technical replicates, 10 
biological replicates, 1 ventricle per replicate, ****P<0.0001; **P<0.01; *P<0.05 by one-
way ANOVA followed by Tukey’s multiple comparisons test). See also Figure S2. (M,N) 
Single confocal sections of ect2 RNAScope (arrowheads) in UI and 7 dpr hearts. Boxed 
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regions are shown at higher magnifications. n=4 hearts per group with 3 sections per heart. 
Asterisk indicates wound edge. Scale bars: 50 μm. CM, cardiomyocytes.
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Figure 2. Loss of Ect2 function causes polyploidization of zebrafish cardiomyocytes
(A–C) Confocal projections of 72 hpf embryonic hearts from control (CTRL), ect2−/−, and 
Tg(cmlc2:GdnEct2) animals carrying the Tg(cmlc2:nucDsRed) transgene. Single confocal 
planes of boxed regions are shown at higher magnification with Alcama immunostaining to 
highlight plasma membranes. White and yellow arrows indicate diploid and polyploid 
cardiomyocytes, respectively. See also Figures S3 and S4A–S4F. (D) Quantification of 
indicated cardiomyocyte populations in the indicated cohorts at 72 hpf (mean±s.d, n=4, 4 
and 4 embryos for ect2+/+, ect2−/−, non-Tg, and Tg(cmlc2:dnEct2), respectively. 
****P<0.0001; ***P<0.001; **P<0.01; *P<0.05 by one-way ANOVA followed by Tukey’s 
multiple comparisons test. (E) 45 dpf (e19.5 mm SSL) Tg(cmlc2:GdnEct2) and non-Tg 
sibling animals with arrowheads highlighting scale bristling (green), blood pooling (white), 
and pericardial edema (purple) in Tg(cmlc2:dnEct2) zebrafish. 68/77 Tg(cmlc2:GdnEct2) 
and 0/88 non-Tg siblings developed these phenotypes. (F) Representative Kaplan-Meier plot 
for Tg(cmlc2:GdnEct2) and non-Tg cluchmates from one of three independent experiments. 
77 total Tg(cmlc2:GdnEct2) animals and 88 total siblings were followed; ****P<0.0001, 
Log-rank test. (G,H) Confocal projections of DAPI-stained whole hearts from 30 dpf non-
Tg or Tg(cmlc2:GdnEct2) animals carrying the Tg(cmlc2:nucDsRed) reporter. 19/25 
transgenic animals showed this phenotype with 6/25 showing an intermediate phenotype. 
(I,J) Ventricular sections from 30 dpf non-Tg or Tg(cmlc2:GdnEct2) animals 
immunostained to detect Tropomyosin and counterstained with DAPI. Boxed regions show 
DAPI staining at higher magnifications. (K,L) Nuclear DNA content distributions of non-
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cardiomyocyte and cardiomyocyte populations from indicated cohorts. Representative data 
are shown from one of four replicates, one heart per replicate. See also Figure S4G–S4I. AT, 
atrium; BA, bulbus arteriosus; V, ventricle; Scale bars: 25 μm (A–C, G–H), 10 mm (E), 100 
μm (I,J).
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Figure 3. Experimental strategy to generate mosaic hearts containing permanently labeled 
polyploid cardiomyocytes through transient cytokinesis inhibition
(A–C) Transgenes and experimental strategy used to create adult zebrafish with mosaic 
hearts composed of diploid (GFP−) and polyploid-enriched (GFP+) cardiomyocyte 
populations. Detailed description of the experimental strategy is provided in Figure S5. (D) 
External appearance of a double-transgenic adult zebrafish with a mosaic heart comprised of 
GFP− diploid and GFP+ polyploid-enriched cardiomyocytes. (E) Adjacent sections from an 
adult mosaic heart immunostained for Tropomyosin and GFP (left) or stained with AFOG 
(right). Boxed area shows apex region at higher magnification. (F) Quantification of the 
percentage of GFP+ myocardium relative to the total ventricular myocardium from mosaic 
adult hearts (n=19). (G) DNA content of GFP− (mO+) and GFP+ cardiomyocytes from 
mosaic hearts. (H) Quantification of indicated cardiomyocyte populations from (F) (mean
±s.d., n=620 and 520 total cells from 4 and 3 biological replicates per group, respectively; 3 
ventricles per replicate; ****P<0.0001; ***P<0.001 by one-way ANOVA followed by 
Tukey’s multiple comparisons test). (I) Dissociated cardiomyocytes from a mosaic heart 
immunostained for Tropomyosin and GFP. Boxed regions show DAPI staining. Shown are 
diploid (top), mononucleated tetraploid (middle) and binucleated tetraploid (bottom) 
cardiomyocytes. (J) Quantification of cardiomyocyte size from the indicated classes from 
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ventricular dissociations (n=822, 84 and 97 cardiomyocytes; ****P<0.0001; Kruskal-Wallis 
test followed by Dunn’s multiple comparisons test). Scale bars: 5 mm (D) 100 μm (E), 25 
μm (I). CM, cardiomyocyte; ER, early recombination; HS, heat-shocked.
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Figure 4. Experimental strategy to generate hearts highly enriched in permanently labeled 
polyploid cardiomyocytes through transient cytokinesis inhibition
(A,B) Transgenes and experimental strategy employed to maximize the percentage of 
cardiomyocytes susceptible to polyploidization. (C) External appearance of double-
transgenic adult zebrafish, subjected to early recombination during embryogenesis, grown in 
the absence (top) or presence (bottom) of polyploid-inducing heat-shock treatments. (D) 
Adjacent sections from a fully recombined adult heart immunostained for Tropomyosin and 
GFP (left) or stained with AFOG (right). Boxed area shows apex region at higher 
magnification. (E) DNA content of GFP+ cardiomyocytes from the indicated cohorts. (F) 
Quantification of indicated cardiomyocyte populations from l (mean±s.d., n=564 and 406 
total cardiomyocytes from 4 and 4 pooled ventricles, respectively, ***P<0.001; **P<0.01, 
by one-way ANOVA followed by Tukey’s multiple comparisons test). See also Figure S6. 
Scale bars: 5 mm (C) 100 μm (D). CM, cardiomyocyte; ER, early recombination; HS, heat-
shocked.
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Figure 5. Myocardial polyploidization creates a barrier to cardiomyocyte proliferation and heart 
regeneration
(A–D) Adjacent sections from 45 dpr hearts from the indicated cohorts, immunostained for 
Tropomyosin and GFP (left) or stained with AFOG (right). n = 14 (12), 10 (9), 9 (9), 19 (18) 
hearts (number of hearts that showed complete regeneration indicated within the brackets), 
respectively. (E) Relative change in percentage of GFP+ cardiomyocytes in the regenerate 
compared to the surrounding region in hearts from the indicated cohorts (n=12, 9 and 19, 
respectively). ***P<0.001; **P<0.01; Kruskal-Wallis test followed by Dunn’s multiple 
comparisons test. (F) Quantification of the scar area of hearts from (A–D) normalized to the 
ventricular area (n= 14, 10, 19 hearts; solid black line indicates the mean); n.s., not 
significant by Kruskal-Wallis test. (G) BrdU pulse-chase strategy used to evaluate 
cardiomyocyte proliferation during regeneration in experiments from G–H. (H) Section 
from a 14 dpr mosaic heart composed of diploid (GFP−) and polyploid-enriched (GFP+) 
cardiomyocyte populations, immunostained for Tropomyosin, GFP, Mef2 and BrdU. BrdU 
and Mef2/GFP signals of boxed region are shown at higher magnifications. Blue arrowheads 
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indicate BrdU+ cardiomyocyte nuclei. (I) Cardiomyocyte BrdU labeling indices of GFP− 
and GFP+ populations in injury sites in experiments from F–G. Box-and-whisker plot. n = 7 
hearts. **P < 0.01, Mann–Whitney test. See also Figure S6. CM, cardiomyocyte; ER, early 
recombination; HS, heat-shocked. Scale bars: 50 μm.
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Figure 6. Increasing the proportion of polyploid cardiomyocytes impairs heart regeneration
(A–C) Adjacent sections from 45 dpr hearts from the indicated cohorts, immunostained for 
Tropomyosin and GFP (left) or stained with AFOG (right). n = 2 (0), 5 (5), 9 (0) hearts 
(number of hearts that showed complete regeneration indicated within the brackets), 
respectively. (D) Quantification of the scar area of hearts from (B,C) normalized to the 
ventricular area (n= 5, 9 hearts; solid black line indicates the mean); ***P<0.001, two-tailed 
unpaired t-test. (E–G) Sections from 14 dpr hearts of the indicated cohorts, immunostained 
for Mef2 and BrdU, as described in Figure 5G–5H. White arrows indicate BrdU+ 
cardiomyocyte nuclei. (H) Cardiomyocyte BrdU labeling index in injury sites in 
experiments from (E–G). Box-and-whisker plot. n = 11, 10, 7 ventricles, respectively. 
****P<0.0001; **P<0.01 by one-way ANOVA followed by Tukey’s multiple comparisons 
test). See also Figures S7 and S8. CM, cardiomyocyte; ER, early recombination; HS, heat-
shocked. Scale bars: 50 μm.
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Figure 7. Model of cardiomyocyte polyploidization as a barrier to heart regeneration
(A) Hearts composed almost exclusively of diploid cardiomyocytes (1x2c), such as those in 
the adult zebrafish and mouse neonate, regenerate efficiently after amputation through 
myocardial proliferation. (B) In mosaic hearts composed of diploid (GFP−) and polyploid-
enriched (GFP+) cardiomyocyte populations, diploid cardiomyocytes proliferate actively to 
replace injured muscle, with minor contributions from the polyploid-enriched population. 
(C) Minimizing the proportion of diploid cardiomyocytes in the zebrafish heart, a situation 
similar to that in adult mammals, including humans, results in reduced cardiomyocyte 
proliferation and persistent scarring. Dashed line, plane of amputation; dark area, amputated 
tissue; blue boxes, regenerated myocardium; red and green cells, diploid and polyploid-
enriched cardiomyocyte populations.
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